Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis

Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental immunology 2001-08, Vol.125 (2), p.332-339
Hauptverfasser: Balding, C. E. J., Howie, A. J., Drake‐Lee, A. B., Savage, C. O. S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 339
container_issue 2
container_start_page 332
container_title Clinical and experimental immunology
container_volume 125
creator Balding, C. E. J.
Howie, A. J.
Drake‐Lee, A. B.
Savage, C. O. S.
description Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studies using peripheral blood T cells have implicated IFN‐γ rich Th1‐type responses. This study addressed the cytokine milieu in nasal mucosa from 10 patients with active Wegener's granulomatosis using immunohistochemistry. Increased levels of CD3+ T cells and eosinophils were present compared with normal and disease controls. There was increased expression of IL‐4, down‐regulation of IL‐2 and no detectable IFN‐γ. There was increased expression of the chemokine receptor CCR3 by infiltrating cells, consistent with an IL‐4 dominant, Th2‐biased response. In contrast, renal biopsy tissue from 10 patients with active Wegener's granulomatosis showed expression of IL‐2 and IL‐4. The Th2‐type environment within nasal mucosa, often the initial site of disease activity in Wegener's, is consistent with a local allergic response in these patients.
doi_str_mv 10.1046/j.1365-2249.2001.125002332.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1906130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18140346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5744-efcd63abd8a41d5c63352a086e3be0e37ffdfce5d3c85bcf1626af7dadbb53aa3</originalsourceid><addsrcrecordid>eNqVkc9u1DAQhy0EokvhFVCEoLcE_08iIaRqVWClSlyKOFoTx9n1KrEXO6Htjdfo6_EkON3VFrggTtbI3_xm7A-h1wQXBHP5dlsQJkVOKa8LijEpCBUYU8ZocfMILY6Xj9ECY1zndeo6Qc9i3KZSSkmfohNCBK1rWi7Q6mpDs9YP1oHTJrMucxChz4ZJ-whzvYPRGjfG7NqOm-yrWRtnws8fdzFbB3BT7wcYfbTxOXrSQR_Ni8N5ir58uLhafsovP39cLc8vcy1KznPT6VYyaNoKOGmFlowJCriShjUGG1Z2XdtpI1qmK9HojkgqoStbaJtGMAB2it7vc3dTM5hWp90C9GoX7ADhVnmw6s8bZzdq7b8rUmNJGE4BZ4eA4L9NJo5qsFGbvgdn_BRVSQitpRD_BElFOGZcJvDVX-DWT8GlX0hDZVWX_D7t3R7SwccYTHdcmWA1m1VbNctTszw1m1VHs-omtb_8_dkPzQeVCXhzACBq6LskR9v4wPE0Q9xz53vu2vbm9r-WUMuLFRGSs18Pa8Ki</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>196897455</pqid></control><display><type>article</type><title>Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Balding, C. E. J. ; Howie, A. J. ; Drake‐Lee, A. B. ; Savage, C. O. S.</creator><creatorcontrib>Balding, C. E. J. ; Howie, A. J. ; Drake‐Lee, A. B. ; Savage, C. O. S.</creatorcontrib><description>Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studies using peripheral blood T cells have implicated IFN‐γ rich Th1‐type responses. This study addressed the cytokine milieu in nasal mucosa from 10 patients with active Wegener's granulomatosis using immunohistochemistry. Increased levels of CD3+ T cells and eosinophils were present compared with normal and disease controls. There was increased expression of IL‐4, down‐regulation of IL‐2 and no detectable IFN‐γ. There was increased expression of the chemokine receptor CCR3 by infiltrating cells, consistent with an IL‐4 dominant, Th2‐biased response. In contrast, renal biopsy tissue from 10 patients with active Wegener's granulomatosis showed expression of IL‐2 and IL‐4. The Th2‐type environment within nasal mucosa, often the initial site of disease activity in Wegener's, is consistent with a local allergic response in these patients.</description><identifier>ISSN: 0009-9104</identifier><identifier>EISSN: 1365-2249</identifier><identifier>DOI: 10.1046/j.1365-2249.2001.125002332.x</identifier><identifier>PMID: 11529927</identifier><identifier>CODEN: CEXIAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Biopsy ; CD3 Complex - analysis ; CD3 Complex - immunology ; Cells, Cultured ; cytokines ; Cytokines - biosynthesis ; Cytokines - genetics ; Cytokines - immunology ; Female ; Granulomatosis with Polyangiitis - immunology ; Granulomatosis with Polyangiitis - pathology ; Humans ; Immunity, Mucosal ; Immunohistochemistry ; kidney ; Kidney - immunology ; Kidney - pathology ; Male ; Medical sciences ; Middle Aged ; Myeloblastin ; Nasal Mucosa - immunology ; Nasal Mucosa - pathology ; Rheumatic Disease/Vasculitis ; RNA, Messenger - biosynthesis ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Serine Endopeptidases - pharmacology ; Th1 Cells - drug effects ; Th1 Cells - immunology ; Th2 Cells - drug effects ; Th2 Cells - immunology ; vasculitis</subject><ispartof>Clinical and experimental immunology, 2001-08, Vol.125 (2), p.332-339</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. Aug 2001</rights><rights>2001 Blackwell Science Ltd 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5744-efcd63abd8a41d5c63352a086e3be0e37ffdfce5d3c85bcf1626af7dadbb53aa3</citedby><cites>FETCH-LOGICAL-c5744-efcd63abd8a41d5c63352a086e3be0e37ffdfce5d3c85bcf1626af7dadbb53aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906130/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906130/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14104527$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11529927$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balding, C. E. J.</creatorcontrib><creatorcontrib>Howie, A. J.</creatorcontrib><creatorcontrib>Drake‐Lee, A. B.</creatorcontrib><creatorcontrib>Savage, C. O. S.</creatorcontrib><title>Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis</title><title>Clinical and experimental immunology</title><addtitle>Clin Exp Immunol</addtitle><description>Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studies using peripheral blood T cells have implicated IFN‐γ rich Th1‐type responses. This study addressed the cytokine milieu in nasal mucosa from 10 patients with active Wegener's granulomatosis using immunohistochemistry. Increased levels of CD3+ T cells and eosinophils were present compared with normal and disease controls. There was increased expression of IL‐4, down‐regulation of IL‐2 and no detectable IFN‐γ. There was increased expression of the chemokine receptor CCR3 by infiltrating cells, consistent with an IL‐4 dominant, Th2‐biased response. In contrast, renal biopsy tissue from 10 patients with active Wegener's granulomatosis showed expression of IL‐2 and IL‐4. The Th2‐type environment within nasal mucosa, often the initial site of disease activity in Wegener's, is consistent with a local allergic response in these patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>CD3 Complex - analysis</subject><subject>CD3 Complex - immunology</subject><subject>Cells, Cultured</subject><subject>cytokines</subject><subject>Cytokines - biosynthesis</subject><subject>Cytokines - genetics</subject><subject>Cytokines - immunology</subject><subject>Female</subject><subject>Granulomatosis with Polyangiitis - immunology</subject><subject>Granulomatosis with Polyangiitis - pathology</subject><subject>Humans</subject><subject>Immunity, Mucosal</subject><subject>Immunohistochemistry</subject><subject>kidney</subject><subject>Kidney - immunology</subject><subject>Kidney - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myeloblastin</subject><subject>Nasal Mucosa - immunology</subject><subject>Nasal Mucosa - pathology</subject><subject>Rheumatic Disease/Vasculitis</subject><subject>RNA, Messenger - biosynthesis</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Serine Endopeptidases - pharmacology</subject><subject>Th1 Cells - drug effects</subject><subject>Th1 Cells - immunology</subject><subject>Th2 Cells - drug effects</subject><subject>Th2 Cells - immunology</subject><subject>vasculitis</subject><issn>0009-9104</issn><issn>1365-2249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkc9u1DAQhy0EokvhFVCEoLcE_08iIaRqVWClSlyKOFoTx9n1KrEXO6Htjdfo6_EkON3VFrggTtbI3_xm7A-h1wQXBHP5dlsQJkVOKa8LijEpCBUYU8ZocfMILY6Xj9ECY1zndeo6Qc9i3KZSSkmfohNCBK1rWi7Q6mpDs9YP1oHTJrMucxChz4ZJ-whzvYPRGjfG7NqOm-yrWRtnws8fdzFbB3BT7wcYfbTxOXrSQR_Ni8N5ir58uLhafsovP39cLc8vcy1KznPT6VYyaNoKOGmFlowJCriShjUGG1Z2XdtpI1qmK9HojkgqoStbaJtGMAB2it7vc3dTM5hWp90C9GoX7ADhVnmw6s8bZzdq7b8rUmNJGE4BZ4eA4L9NJo5qsFGbvgdn_BRVSQitpRD_BElFOGZcJvDVX-DWT8GlX0hDZVWX_D7t3R7SwccYTHdcmWA1m1VbNctTszw1m1VHs-omtb_8_dkPzQeVCXhzACBq6LskR9v4wPE0Q9xz53vu2vbm9r-WUMuLFRGSs18Pa8Ki</recordid><startdate>200108</startdate><enddate>200108</enddate><creator>Balding, C. E. J.</creator><creator>Howie, A. J.</creator><creator>Drake‐Lee, A. B.</creator><creator>Savage, C. O. S.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Oxford University Press</general><general>Blackwell Science Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200108</creationdate><title>Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis</title><author>Balding, C. E. J. ; Howie, A. J. ; Drake‐Lee, A. B. ; Savage, C. O. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5744-efcd63abd8a41d5c63352a086e3be0e37ffdfce5d3c85bcf1626af7dadbb53aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>CD3 Complex - analysis</topic><topic>CD3 Complex - immunology</topic><topic>Cells, Cultured</topic><topic>cytokines</topic><topic>Cytokines - biosynthesis</topic><topic>Cytokines - genetics</topic><topic>Cytokines - immunology</topic><topic>Female</topic><topic>Granulomatosis with Polyangiitis - immunology</topic><topic>Granulomatosis with Polyangiitis - pathology</topic><topic>Humans</topic><topic>Immunity, Mucosal</topic><topic>Immunohistochemistry</topic><topic>kidney</topic><topic>Kidney - immunology</topic><topic>Kidney - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myeloblastin</topic><topic>Nasal Mucosa - immunology</topic><topic>Nasal Mucosa - pathology</topic><topic>Rheumatic Disease/Vasculitis</topic><topic>RNA, Messenger - biosynthesis</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Serine Endopeptidases - pharmacology</topic><topic>Th1 Cells - drug effects</topic><topic>Th1 Cells - immunology</topic><topic>Th2 Cells - drug effects</topic><topic>Th2 Cells - immunology</topic><topic>vasculitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balding, C. E. J.</creatorcontrib><creatorcontrib>Howie, A. J.</creatorcontrib><creatorcontrib>Drake‐Lee, A. B.</creatorcontrib><creatorcontrib>Savage, C. O. S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and experimental immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balding, C. E. J.</au><au>Howie, A. J.</au><au>Drake‐Lee, A. B.</au><au>Savage, C. O. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis</atitle><jtitle>Clinical and experimental immunology</jtitle><addtitle>Clin Exp Immunol</addtitle><date>2001-08</date><risdate>2001</risdate><volume>125</volume><issue>2</issue><spage>332</spage><epage>339</epage><pages>332-339</pages><issn>0009-9104</issn><eissn>1365-2249</eissn><coden>CEXIAL</coden><abstract>Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studies using peripheral blood T cells have implicated IFN‐γ rich Th1‐type responses. This study addressed the cytokine milieu in nasal mucosa from 10 patients with active Wegener's granulomatosis using immunohistochemistry. Increased levels of CD3+ T cells and eosinophils were present compared with normal and disease controls. There was increased expression of IL‐4, down‐regulation of IL‐2 and no detectable IFN‐γ. There was increased expression of the chemokine receptor CCR3 by infiltrating cells, consistent with an IL‐4 dominant, Th2‐biased response. In contrast, renal biopsy tissue from 10 patients with active Wegener's granulomatosis showed expression of IL‐2 and IL‐4. The Th2‐type environment within nasal mucosa, often the initial site of disease activity in Wegener's, is consistent with a local allergic response in these patients.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>11529927</pmid><doi>10.1046/j.1365-2249.2001.125002332.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9104
ispartof Clinical and experimental immunology, 2001-08, Vol.125 (2), p.332-339
issn 0009-9104
1365-2249
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1906130
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Biological and medical sciences
Biopsy
CD3 Complex - analysis
CD3 Complex - immunology
Cells, Cultured
cytokines
Cytokines - biosynthesis
Cytokines - genetics
Cytokines - immunology
Female
Granulomatosis with Polyangiitis - immunology
Granulomatosis with Polyangiitis - pathology
Humans
Immunity, Mucosal
Immunohistochemistry
kidney
Kidney - immunology
Kidney - pathology
Male
Medical sciences
Middle Aged
Myeloblastin
Nasal Mucosa - immunology
Nasal Mucosa - pathology
Rheumatic Disease/Vasculitis
RNA, Messenger - biosynthesis
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Serine Endopeptidases - pharmacology
Th1 Cells - drug effects
Th1 Cells - immunology
Th2 Cells - drug effects
Th2 Cells - immunology
vasculitis
title Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T00%3A31%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Th2%20dominance%20in%20nasal%20mucosa%20in%20patients%20with%20Wegener%E2%80%99s%20granulomatosis&rft.jtitle=Clinical%20and%20experimental%20immunology&rft.au=Balding,%20C.%20E.%20J.&rft.date=2001-08&rft.volume=125&rft.issue=2&rft.spage=332&rft.epage=339&rft.pages=332-339&rft.issn=0009-9104&rft.eissn=1365-2249&rft.coden=CEXIAL&rft_id=info:doi/10.1046/j.1365-2249.2001.125002332.x&rft_dat=%3Cproquest_pubme%3E18140346%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=196897455&rft_id=info:pmid/11529927&rfr_iscdi=true